相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PP242 suppresses cell proliferation, metastasis, and angiogenesis of gastric cancer through inhibition of the PI3K/AKT/mTOR pathway
Xiaofang Xing et al.
ANTI-CANCER DRUGS (2014)
EBP50 inhibits the migration and invasion of human breast cancer cells via LIMK/cofilin and the PI3K/Akt/mTOR/MMP signaling pathway
Hongli Li et al.
MEDICAL ONCOLOGY (2014)
FTY720 reduces migration and invasion of human glioblastoma cell lines via inhibiting the PI3K/AKT/mTOR/p70S6K signaling pathway
Li Zhang et al.
TUMOR BIOLOGY (2014)
The mechanisms of nadroparin-mediated inhibition of proliferation of two human lung cancer cell lines
Y. Carmazzi et al.
CELL PROLIFERATION (2012)
Modulating the interaction of CXCR4 and CXCL12 by low-molecular-weight heparin inhibits hepatic metastasis of colon cancer
Lixin Ma et al.
INVESTIGATIONAL NEW DRUGS (2012)
Fucoidan from Seaweed Fucus vesiculosus Inhibits Migration and Invasion of Human Lung Cancer Cell via PI3K-Akt-mTOR Pathways
Hyunkyoung Lee et al.
PLOS ONE (2012)
Downregulation of Akt and FAK phosphorylation reduces invasion of glioblastoma cells by impairment of MT1-MMP shuttling to lamellipodia and downregulates MMPs expression
Aneta Kwiatkowska et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Concentration- and time-dependent effects of enoxaparin on human adenocarcinomic epithelial cell line A549 proliferation in vitro
Walid Abu Arab et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2011)
Low molecular weight heparin inhibits melanoma cell adhesion and migration through a PKCa/JNK signaling pathway inducing actin cytoskeleton changes
Georgia Chalkiadaki et al.
CANCER LETTERS (2011)
Targeting phosphoinositide 3-kinase signalling in lung cancer
Anna Wojtalla et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2011)
CXC receptor-4 mRNA silencing abrogates CXCL12-induced migration of colorectal cancer cells
Claudia Rubie et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Effect of tinzaparin on survival in non-small-cell lung cancer after surgery. TILT: Tinzaparin in lung tumours
G. Meyer et al.
REVUE DES MALADIES RESPIRATOIRES (2011)
The role of chemokine receptor CXCR4 in lung cancer
Tara Gangadhar et al.
CANCER BIOLOGY & THERAPY (2010)
CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
Beverly A. Teicher et al.
CLINICAL CANCER RESEARCH (2010)
Antitumor Effect of Butanoylated Heparin with Low Anticoagulant Activity on Lung Cancer Growth in Mice and Rats
Lunyin Yu et al.
CURRENT CANCER DRUG TARGETS (2010)
Inhibitory effects of andrographolide on migration and invasion in human non-small cell lung cancer A549 cells via down-regulation of PI3K/Akt signaling pathway
Yi-Chieh Lee et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
High antiangiogenic and low anticoagulant efficacy of orally active low molecular weight heparin derivatives
Jin Woo Park et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Early Palliative Care for Patients with Metastatic Non-Small-Cell Lung Cancer
Jennifer S. Temel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Isoform-selective phosphoinositide 3′-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach
Matthias Niedermeier et al.
BLOOD (2009)
FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer
Gareth O. Griffiths et al.
BMC CANCER (2009)
EMT, the cytoskeleton, and cancer cell invasion
Mahmut Yilmaz et al.
CANCER AND METASTASIS REVIEWS (2009)
Class IA Phosphatidylinositol 3-Kinase Signaling in Non-small Cell Lung Cancer
Benjamin Solomon et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
The Effect of LMWH (Nadroparin) on Tumor Progression
Zsuzsanna Nagy et al.
PATHOLOGY & ONCOLOGY RESEARCH (2009)
The effect of dalteparin, a kind of low molecular weight heparin, on lung adenocarcinoma A549 cell line in vitro
Xiaojun Chen et al.
CANCER INVESTIGATION (2008)
A novel lung cancer signature mediates metastatic bone colonization by a dual mechanism
Silvestre Vicent et al.
CANCER RESEARCH (2008)
Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis
Chih-Hsin Tang et al.
CARCINOGENESIS (2008)
American society of clinical oncology guideline: Recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer
Gary H. Lyman et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Modulatory effects of heparin and short-length oligosaccharides of heparin on the metastasis and growth of LMD MDA-MB 231 breast cancer cells in vivo
P. Mellor et al.
BRITISH JOURNAL OF CANCER (2007)
Low molecular weight heparin (LMWH) increases the efficacy of cisplatinum plus gemcitabine combination in advanced pancreatic cancer
Fikri Icli et al.
JOURNAL OF SURGICAL ONCOLOGY (2007)
The effect of low-molecular-weight heparin on cancer survival. A systematic review and meta-analysis of randomized trials
A. Lazo-Langner et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Inhibition of CXCR4-mediated breast cancer metastasis: A potential role for heparinoids?
James R. Harvey et al.
CLINICAL CANCER RESEARCH (2007)
Anti-metastatic activity of heparin is probably associated with modulation of SDF-1-CXCR4 axis
Marian Simka
MEDICAL HYPOTHESES (2007)
Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion
Angela Sutton et al.
MOLECULAR CANCER RESEARCH (2007)
Metastasis: a question of life or death
P Mehlen et al.
NATURE REVIEWS CANCER (2006)
Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells
LP Su et al.
CLINICAL CANCER RESEARCH (2005)
Heparin octasaccharides inhibit angiogenesis in vivo
J Hasan et al.
CLINICAL CANCER RESEARCH (2005)
Heparin and CXCL12 dimerization
K Altundag et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism
AYY Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The effect of low molecular weight heparin on survival in patients with advanced malignancy
CPW Klerk et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Selective antimetastatic effect of heparins in preclinical human melanoma models is based on inhibition of migration and microvascular arrest
B Bereczky et al.
CLINICAL & EXPERIMENTAL METASTASIS (2005)
A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer
M Altinbas et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Microfilament actin remodeling as a potential target for cancer drug development
JY Rao et al.
CURRENT CANCER DRUG TARGETS (2004)
Phospho-Akt overexpression in non-small cell lung cancer confers significant stage-independent survival disadvantage
O David et al.
CLINICAL CANCER RESEARCH (2004)
Characterization of the stromal cell-derived factor-lα-heparin complex
R Sadir et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Involvement of chemokine receptors in breast cancer metastasis
A Müller et al.
NATURE (2001)
分享论文
